Join the Conversation
See our latests posts
A paper recently was published on the study design and Phase 1 results of the AZIMUTH study representing a successful partnership between leading Italian medical centers, AstraZeneca, and Healthentia, demonstrating how collaborative innovation can transform healthcare delivery. This multicenter initiative leveraged Healthentia Medical Device (SaMD), to address the persistent challenges in heart failure management. The...
In the evolving landscape of digital health, understanding and supporting patient adherence to treatment remains a top priority especially in chronic disease management. Innovation Sprint is a proud partner of the Innovative Medicines Initiative IMI, BEAMER project that addresses this need with the development of B-COMPASS (BEAMER-Computational Model for Patient Adherence and Support Solutions), a...
Our team is growing! Let’s give a warm welcome to Ioannis, the newest member of our group. We are excited to get to know him better! I am Ioannis Kyriakos, and I am happy to be joining the Healthentia team as a Data Science Director as of April 2025. I hold a BSc in...
Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires a comprehensive and innovative approach. As part of the RE-SAMPLE research project, Healthentia, our advanced SaMD solution, addresses this challenge by integrating real-world data (RWD) to enhance disease management and improve daily life for patients. For more information about the intended...
World Diabetes Day is an essential reminder of the global impact of diabetes. Especially type 2 diabetes affects millions of lives and continues to grow at an alarming rate. Currently, type 2 diabetes makes up more than 90% of the over 450 million adults worldwide that are living with diabetes. By 2030, this number is...